Ampreloxetine is under investigation in clinical trial NCT03750552 (Clinical Effect of TD-9855 for Treating snOH in Subjects With Primary Autonomic Failure).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.